Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 5 de 5
Filter
Add more filters










Database
Publication year range
1.
J Med ; 24(1): 75-96, 1993.
Article in English | MEDLINE | ID: mdl-8501405

ABSTRACT

The authors describe a case similar to the complex syndrome described by Seckel (1960), "dwarf-headed dwarfism." This case differs from others previously reported because of slight hypophyseal hypoplasia with a slight reduction of human chorionic gonadotrophin (HCG) serum levels, and because of the parent's consanguinity (first cousins). A comparative critical examination was carried out on the 44 cases of Seckel's syndrome described in the literature. Only 19 of these cases appear to be comparable with Seckel's description, while the others are dubious, due to incomplete data. Some can be identified as ordinary cases of dwarfism with microcephaly or mental deficit. Until more precise and objective parameters are established, it would be advisable to refer to this particular form of dwarfism as "Virchow-Seckel type dwarf-headed dwarfism," in order to avoid using the more binding term "syndrome" and the misleading term "bird-headed."


Subject(s)
Abnormalities, Multiple/diagnostic imaging , Clubfoot/diagnostic imaging , Dwarfism/diagnostic imaging , Heart Defects, Congenital/diagnostic imaging , Intellectual Disability , Microcephaly/diagnostic imaging , Scoliosis/diagnostic imaging , Adult , Consanguinity , Dwarfism/metabolism , Female , Humans , Radiography
2.
G Clin Med ; 71(12): 727-31, 1990 Dec.
Article in Italian | MEDLINE | ID: mdl-2150826

ABSTRACT

Indobufen (200 mg b.i.d., by os, for 21 days) was gave to 16 patients with atherothrombotic risk in which platelet function was valued. In this subjects, indobufen significatively reduced platelet aggregation, beta-thromboglobulin, platelet factor the 4th and alpha-platelet granules' intake. No side effects were found.


Subject(s)
Blood Platelets/drug effects , Phenylbutyrates/pharmacology , Platelet Aggregation Inhibitors/pharmacology , Thrombosis/prevention & control , Aged , Female , Humans , Isoindoles , Male , Middle Aged , Phenylbutyrates/administration & dosage , Platelet Aggregation/drug effects , Platelet Aggregation Inhibitors/administration & dosage , Time Factors , beta-Thromboglobulin/analysis
3.
Minerva Med ; 78(22): 1655-63, 1987 Nov 30.
Article in Italian | MEDLINE | ID: mdl-3696444

ABSTRACT

The effects of environmental hyperthermia (exposure to a hot, dry microclimate) on the human body were investigated with particular reference to certain clotting parameters in healthy subjects and patients at risk of thrombosis. The study covered 70 volunteers, 10 of them clinically healthy (6 males and 4 females) aged 37.7 +/- 9.7 and 60 patients at risk of thrombosis aged 18-60 and divided according to pathology as follows: 26 with ischaemic cardiopathy, 22 with metabolic disorders (12 diabetics, 8 with dyslipidaemia, 2 with hyperuricaemia) and 12 with obliterating arteriopathies of the lower extremities (Fontaine stage 2 and 3). The following standardised protocol was adopted: 2 hours exposure in a controlled climate chamber (40 degrees C, 40-50% humidity, standard air speed 4 m/min, barometric pressure 760 mmHg) for a total of 8 exposures (2 per week for 1 month). This approach was adopted in order to assess not only the effect of each single exposure but also the role of any adaptation to heat. Three blood samples were taken from each subject for each session: the first in basal conditions in a comfortable environment, the second at the end of the 2 hour exposure; the third 30 minutes after the end of the session. Simultaneously samples of arterial blood were taken for pH assays and a spleen echography was performed in basal conditions and at the end of the session for each subject. Each blood sample was tested for several parameters essentially attributable to blood concentration for a broader view of the biological effects of exposure to heart (Ht, blood protein, Nat, K+). The clotting factors under specific study were also assessed (platelet count and volume, beta-thromboglobulin, PF4, von Willebrand Factor VIII, thromboxane B2, fibronectin). Body weight, blood pressure and oral temperature were also measured in all subjects before and after each session. In all subjects both healthy and at risk of thrombosis oral temperature increased (1 +/- 0.4 degrees); on average blood pressure was already higher in basal conditions in the patient group; body weight fell by 900 +/- 120 G in both groups. Ht and blood protein increased significantly in both groups while electrolyte changes were insignificant and blood pH showed a tendency towards acidosis. Clotting parameters revealed a tendency towards thrombophilia in all subjects: platelet count and volume were already higher in the patient group in basal conditions and increased after exposure to hyperthermia. Beta-thromboglobulin, FP4, Factor VIII, thromboxane B2 and fibronectin all increased.(ABSTRACT TRUNCATED AT 400 WORDS)


Subject(s)
Blood Coagulation , Hot Temperature/adverse effects , Thrombosis/blood , Adolescent , Adult , Blood Coagulation Factors/metabolism , Blood Platelets/cytology , Blood Pressure , Body Temperature , Female , Humans , Male , Middle Aged , Platelet Count , Serum Globulins/metabolism
SELECTION OF CITATIONS
SEARCH DETAIL
...